Noninferior crossover study to evaluate blood testosterone improvement using new testosterone gel.

Noninferior crossover study to evaluate blood testosterone improvement using new testosterone gel. - The study to evaluate blood testosterone improvement using new testosterone gel.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000034704

Enrollment

Registered

2018-10-30

Start date

2018-10-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Late onset hypogonadism

Interventions

new testosterone gel for 4 weeks AndroForte 2 for 4 weeks as a standard treatment

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Japanese men with mild LOH (more than 27 of Aging males' symptoms score (AMS score)

Exclusion criteria

Exclusion criteria: Prostatic cancer Polycythemia Sleep apnea syndrome

Design outcomes

Primary

Measure	Time frame
blood testosterone level	—

Secondary

Measure	Time frame
Aging Males' Symptoms Score	—

Countries

Japan

Contacts

Public ContactMasato Shirai

Juntendo University Urayasu Hospital Department of Urology

masatos@juntendo-urayasu.jp+81473533111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026